The latest closing stock price for NeuroBo Pharmaceuticals as of September 18, 2024 is 3.40.
An investor who bought $1,000 worth of NeuroBo Pharmaceuticals stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -70.24% compound annual growth rate over 8 years.
The all-time high NeuroBo Pharmaceuticals stock closing price was 126419.99 on July 31, 2017.
The NeuroBo Pharmaceuticals 52-week high stock price is 6.75, which is 98.5% above the current share price.
The NeuroBo Pharmaceuticals 52-week low stock price is 2.90, which is 14.7% below the current share price.
The average NeuroBo Pharmaceuticals stock price for the last 52 weeks is 3.98.
An investor who bought $1,000 worth of NeuroBo Pharmaceuticals stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -70.24% compound annual growth rate over 8 years.
The all-time high NeuroBo Pharmaceuticals stock closing price was 126419.99 on July 31, 2017.
The NeuroBo Pharmaceuticals 52-week high stock price is 6.75, which is 98.5% above the current share price.
The NeuroBo Pharmaceuticals 52-week low stock price is 2.90, which is 14.7% below the current share price.
The average NeuroBo Pharmaceuticals stock price for the last 52 weeks is 3.98.